Advertisement
Screener

INVIVYD, INC. (IVVD) ROA

INVIVYD, INC. (IVVD) ROA

  • 2026-06-30: ROA -49.04%.
  • 2026-03-31: ROA -32.10%.
  • 2025-12-31: ROA -18.96%.
  • 2025-09-30: ROA -43.02%.

Complete source-backed roa history.

Available history
2021-06-30 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-49.04%
2026-03-31-32.10%
2025-12-31-18.96%
2025-09-30-43.02%
2025-06-30-123.55%
2025-03-31-137.57%
2024-12-31-131.20%
2024-09-30-139.04%
2024-06-30-114.94%
2024-03-31-95.99%
2023-12-31-86.68%
2023-09-30-61.68%
2023-06-30-55.55%
2023-03-31-50.20%
2022-12-31-62.98%
2022-09-30-65.87%
2022-06-30-60.89%
2022-03-31-51.91%
2021-12-31-36.57%
2021-09-30-27.94%
2021-06-30-33.04%

Annual ROA

DateROA
2025-12-31-18.96%
2024-12-31-131.20%
2023-12-31-86.68%
2022-12-31-62.98%
2021-12-31-36.57%

Similar stocks

Stock NameCountryMarket CapPE Ratio
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51
Liminatus Pharma, Inc. (LIMN)United States$0.282B
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
X4 Pharmaceuticals, Inc (XFOR)United States$0.297B-4.99
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
SAB Biotherapeutics, Inc. (SABS)United States$0.306B-25.49